Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (33 quarters reported)
$760M in Q4 2015 → $2.12M now. Hover for any quarter.
As reported for the quarter ended December 31, 2023. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| SH Streamline Health Solutions Ord | 100.0% | Unchanged | 4,930,882 | $2.12M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended December 31, 2023 · filed February 09, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SN Spy Nov3 400.0 P | Exited | −150,000 | −$64.1M | — |
| BO Bdx Oct3 275.0 C | Exited | −65,000 | −$16.8M | — |
| DO Dxcm Oct3 110.0c | Exited | −100,000 | −$9.33M | — |
| VO Viatris Ord | Exited | −675,000 | −$6.66M | — |
| BD Becton Dickinson Ord | Exited | −25,000 | −$6.46M | — |
| VO Vtrs Oct3 11.0 C | Exited | −600,000 | −$5.92M | — |
| VO Veradigm Ord | Exited | −435,000 | −$5.72M | — |
| MO Mckesson Ord | Exited | −11,000 | −$4.78M | — |
| TO Tlt Oct3 100.0 C | Exited | −50,000 | −$4.43M | — |
| CP Collegium Pharmaceutical Ord | Exited | −185,000 | −$4.13M | — |
Showing the 10 largest of 20 changes.
quarter ended September 30, 2023 · filed November 16, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Trust Jul3 425.0 P | Exited | −400,000 | −$175M | — |
| SN Spy Nov3 400.0 P | New | +150,000 | +$64.1M | 41.5% |
| BO Bdx Oct3 275.0 C | New | +65,000 | +$16.8M | 10.9% |
| I2 Ishares 20 Plus Year Treasury Bond ETF Sep3 110.0 C | Exited | −150,000 | −$15.4M | — |
| DO Dxcm Oct3 110.0c | New | +100,000 | +$9.33M | 6.0% |
| VO Veradigm Ord | Trimmed | −495,000 | −$6.5M | 3.7% |
| BP Biomarin Pharmaceutical Ord | Exited | −75,000 | −$6.5M | — |
| VO Vtrs Oct3 11.0 C | New | +600,000 | +$5.92M | 3.8% |
| VO Viatris Ord | Trimmed | −575,000 | −$5.67M | 4.3% |
| TH Tenet Healthcare Ord | Trimmed | −75,000 | −$4.94M | 0.9% |
Showing the 10 largest of 39 changes.
quarter ended June 30, 2023 · filed August 10, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Trust Jul3 425.0 P | New | +400,000 | +$175M | 54.2% |
| Q1 Qqq 1ap3 295.0 P | Exited | −250,000 | −$80.2M | — |
| SA Spy Apr3 370.0 P | Exited | −100,000 | −$40.9M | — |
| I2 Ishares 20 Plus Year Treasury Bond ETF Sep3 110.0 C | New | +150,000 | +$15.4M | 4.8% |
| RA Rsp Apr3 155.0 C | Exited | −100,000 | −$14.5M | — |
| AO Amgen Ord | Exited | −30,000 | −$7.25M | — |
| BP Biomarin Pharmaceutical Ord | New | +75,000 | +$6.5M | 2.0% |
| AL Abbott Laboratories Ord | New | +45,000 | +$4.91M | 1.5% |
| MO Mckesson Ord | Added | +11,000 | +$4.7M | 1.8% |
| DO Docgo Ord | Trimmed | −475,000 | −$4.45M | 0.4% |
Showing the 10 largest of 48 changes.
quarter ended March 31, 2023 · filed May 11, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Q1 Qqq 1ap3 295.0 P | Added | +100,000 | +$32.1M | 29.3% |
| SA Spy Apr3 370.0 P | Added | +75,000 | +$30.7M | 15.0% |
| RA Rsp Apr3 155.0 C | New | +100,000 | +$14.5M | 5.3% |
| AO Amgen Ord | New | +30,000 | +$7.25M | 2.7% |
| BJ Bdx Jan3 260.0 P | Exited | −25,000 | −$6.36M | — |
| AO Alkermes Ord | Trimmed | −200,000 | −$5.64M | 0.8% |
| BO Biogen Ord | Exited | −20,000 | −$5.54M | — |
| LH Lantheus Holdings Ord | Exited | −105,000 | −$5.35M | — |
| VO Viatris Ord | Added | +525,000 | +$5.05M | 5.3% |
| TA Tdoc Apr3 20.0 P | New | +150,000 | +$3.89M | 1.4% |
Showing the 10 largest of 45 changes.
quarter ended December 31, 2022 · filed February 13, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| QJ Qqq Jan3 270.0 P | New | +150,000 | +$39.9M | 20.6% |
| Perrigo Co PLC | Exited | −255,000 | −$9.09M | — |
| SJ Spy Jan3 380.0 P | Added | +22,500 | +$8.6M | 4.9% |
| BJ Bdx Jan3 260.0 P | Added | +24,800 | +$6.31M | 3.3% |
| Biomarin Pharmaceutical Inc | Exited | −71,000 | −$6.02M | — |
| C Cigna Corp | Exited | −20,000 | −$5.55M | — |
| BO Biogen Ord | New | +20,000 | +$5.54M | 2.9% |
| B- Bioventus Inc - A | Exited | −750,001 | −$5.25M | — |
| LH Lantheus Holdings Ord | Trimmed | −103,000 | −$5.25M | 2.8% |
| SA Sanofi ADR Rep 1 1/2 Ord | Trimmed | −105,000 | −$5.09M | 1.2% |
Showing the 10 largest of 50 changes.
quarter ended September 30, 2022 · filed November 15, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| C Cigna Corp | Trimmed | −43,000 | −$11.9M | 3.3% |
| United Therapeutics Corp | Exited | −30,000 | −$7.07M | — |
| Streamline Health Solutions | New | +4,930,882 | +$5.87M | 3.4% |
| LC Laboratory Crp Of Amer Hldgs | Exited | −25,000 | −$5.86M | — |
| Amgen Inc | Exited | −24,000 | −$5.84M | — |
| Cvs Health Corp | New | +50,000 | +$4.77M | 2.8% |
| Alkermes PLC | New | +200,000 | +$4.47M | 2.6% |
| Merck & Co. Inc. | Trimmed | −50,000 | −$4.31M | 1.3% |
| Biomarin Pharmaceutical Inc | Added | +41,000 | +$3.48M | 3.5% |
| Collegium Pharmaceutical Inc | Added | +200,000 | +$3.2M | 2.8% |
Showing the 10 largest of 47 changes.
quarter ended June 30, 2022 · filed August 16, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Medtronic PLC | Exited | −75,000 | −$8.32M | — |
| Perrigo Co PLC | New | +200,000 | +$8.11M | 4.7% |
| Merck & Co. Inc. | Trimmed | −80,000 | −$7.29M | 4.0% |
| United Therapeutics Corp | New | +30,000 | +$7.07M | 4.1% |
| Perrigo Co PLC | Exited | −175,000 | −$6.73M | — |
| LC Laboratory Crp Of Amer Hldgs | New | +25,000 | +$5.86M | 3.4% |
| Amgen Inc | New | +24,000 | +$5.84M | 3.4% |
| AH Allscripts Healthcare Soluti | Added | +350,000 | +$5.19M | 4.7% |
| Cvs Health Corp | Exited | −50,000 | −$5.06M | — |
| S Sanofi-adr | New | +95,000 | +$4.75M | 2.7% |
Showing the 10 largest of 56 changes.
quarter ended March 31, 2022 · filed May 11, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| C Cigna Corp | Added | +67,000 | +$16.1M | 8.5% |
| Tenet Healthcare Corp | Trimmed | −125,000 | −$10.7M | 3.1% |
| Humana Inc | Exited | −20,000 | −$9.28M | — |
| Biomarin Pharmaceutical Inc | Exited | −90,000 | −$7.95M | — |
| Streamline Health Solutions | Exited | −4,930,882 | −$7.35M | — |
| Merck & Co. Inc. | Added | +85,000 | +$6.97M | 6.0% |
| Perrigo Co PLC | New | +175,000 | +$6.73M | 3.2% |
| Lantheus Holdings Inc | Trimmed | −105,000 | −$5.81M | 6.5% |
| Medtronic PLC | Trimmed | −50,000 | −$5.55M | 3.9% |
| Callaway Golf Company | Exited | −200,000 | −$5.49M | — |
Showing the 10 largest of 63 changes.
Loading...
